| European Case Law Identifier: | ECLI:EP:BA:1999:T037996.19990113 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 13 January 1999 | ||||||||
| Case number: | T 0379/96 | ||||||||
| Application number: | 89312270.5 | ||||||||
| IPC class: | A61K 9/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Medicinal aerosol formulations | ||||||||
| Applicant name: | Riker Laboratories, Inc. | ||||||||
| Opponent name: | (01) Norton Healthcare Ltd (02) Schering Corporation (03) Boehringer Ingelheim GmbH (04) Professor Sylvain RAULT (05) SmithKline Beecham plc (06) Fisons plc |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Inventive step - no - for all admitted requests - obvious substitution of a compound of a composition Request on the basis of Article 125 EPC or Article 32 TRIPS to refer a question of law to the Enlarged Board of Appeal or to the European Court of Justice - not admitted into the proceedings |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960379eu1.html
Date retrieved: 17 May 2021
